Laxatives
High-yield Verified · Oct 2026Laxatives are a class of medications used for constipation.
A mechanism family, not a single drug: bulk-forming, osmotic, stimulant, softener, and lubricant. Match the mechanism and onset to the patient.
How it works in the body
The system involved, what goes wrong, and how the drug and body interact.
01 Five ways to move the bowel — learn the class by mechanism
Unlike the acid drugs, "laxatives" is not one drug with one mechanism — it is a family of mechanisms, and knowing which lever a drug pulls tells you its speed, its use, and its danger. There are five main levers. Bulk-forming agents (psyllium, methylcellulose) are soluble fiber that absorb water into the stool, increasing its mass so the bowel wall stretches and pushes it along — but slow (12–72 h) and not suited to urgent relief. Osmotic agents (PEG 3350, lactulose, magnesium hydroxide/citrate) are poorly absorbed solutes that hold water in the lumen by osmosis, softening and loosening stool.
Stimulant laxatives (bisacodyl, senna) directly stimulate the myenteric nerve plexus, increasing motility and intestinal secretion — fast (oral 6–12 h; suppository within an hour) but prone to cramping and, with chronic overuse, dependence. Stool softeners / emollients (docusate) are surfactants that let water and fat penetrate hard stool — gentle, but the evidence that docusate actually works is weak (near placebo). And lubricants (mineral oil) simply coat the stool for easier passage, at the cost of a real aspiration-pneumonia risk. Newer prescription agents add other mechanisms: secretagogues (lubiprostone, linaclotide) pull fluid into the gut, and peripheral opioid blockers treat opioid-induced constipation.
02 The one rule above all — rule out obstruction first
A central safety concept in this class is a red flag, not a mechanism: never give a laxative before ruling out a bowel obstruction. If the bowel is blocked or not moving — by a tumor, a volvulus, an ileus, a stuck fecal mass, or an inflamed appendix — then stimulating peristalsis or drawing water and gas into the lumen raises pressure against the blockage and can perforate the bowel, a surgical emergency. So laxatives are contraindicated in known or suspected obstruction, ileus, perforation, or an acute abdomen such as appendicitis, and unexplained abdominal pain — especially with nausea, vomiting, and distension — needs evaluation before any laxative.
This is why the nurse assesses the bowel before treating it: bowel sounds, the pattern and last bowel movement, distension, and whether pain is severe, constant, or accompanied by vomiting (possible obstruction). Constipation is treated conservatively first — fluids, fiber, and activity — then with the gentlest effective agent, saving stimulants for short-term use. Getting this order wrong is how a "simple" constipation order becomes a perforation.
03 Why the harms follow — fluid, electrolytes, and two special hazards
Most laxative harm is simply too much of the intended effect: drawing water and speeding transit can cause cramping and diarrhea, and with overuse or high doses, fluid and electrolyte depletion — dehydration, hypokalemia, and hyponatremia — which is dangerous in the elderly and those on diuretics or digoxin. Two mechanism-specific hazards deserve singling out. Magnesium-based osmotics (milk of magnesia, mag citrate) are excreted by the kidney, so in renal impairment the absorbed magnesium builds up to hypermagnesemia (hypotension, bradycardia, depressed reflexes, respiratory depression) — use them cautiously, if at all, in renal disease. Bulk-forming fiber taken without enough water can swell and obstruct the esophagus or bowel — so it is always given with a full glass of fluid and avoided in patients who can’t swallow safely.
A few agent-specific points complete the picture. Mineral oil can be silently aspirated into the lungs (lipoid pneumonia) — avoid it in anyone with swallowing or aspiration risk, and don’t combine it with docusate (which increases its absorption). Chronic stimulant overuse is associated with dependence. And unlike the others, three agents have agent-specific boxed warnings: oral sodium phosphate bowel-prep tablets (now discontinued in the US) caused acute phosphate nephropathy (sometimes permanent kidney injury), and linaclotide (contraindicated < 2 years) and plecanatide (< 6 years) caused fatal dehydration in juvenile animals — these are not class-wide warnings. One bright spot beyond constipation: lactulose treats hepatic encephalopathy — gut bacteria acidify the colon and convert absorbable ammonia (NH₃) into trapped ammonium (NH₄⁺), which is then excreted, lowering blood ammonia; it is titrated to 2–3 soft stools per day.
Drug names
Indications
- Constipation — acute and chronic (conservative measures first)
- Bowel preparation before colonoscopy or surgery (PEG-electrolyte solutions)
- Straining precautions — post-MI, post-surgery, hemorrhoids/anal fissure
- Opioid-induced constipation; hepatic encephalopathy (lactulose)
Mechanism of action
Laxatives promote defecation by several distinct mechanisms: bulk-forming agents absorb water to increase stool mass and distend the bowel (triggering peristalsis); osmotic agents hold water in the lumen by osmosis; stimulant agents excite the myenteric plexus to increase motility and secretion; stool softeners are surfactants that let water and fat penetrate the stool; and lubricants coat the stool. Lactulose additionally acidifies the colon to trap ammonia as ammonium, giving it a role in hepatic encephalopathy.
Therapeutic effects — what you'll see working
The goal is a return to the patient’s normal, comfortable bowel pattern without straining — not diarrhea. Match the mechanism and onset to the need, treat conservatively first, and reserve stimulants for short courses. Success is a soft, formed stool passed without difficulty.
- Softer, easier-to-pass stool
- By adding bulk, holding water, softening, or lubricating, laxatives make stool softer and easier to pass, relieving constipation and preventing straining. Judge success by a comfortable bowel movement, not by producing diarrhea.
- Effective bowel preparation
- High-volume PEG-electrolyte solutions rapidly flush the colon to give a clean field for colonoscopy or surgery — success is judged by the quality of the prep at the procedure.
- Lowered blood ammonia (lactulose in hepatic encephalopathy)
- In hepatic encephalopathy, lactulose acidifies the colon so ammonia is trapped as ammonium and excreted, lowering blood ammonia and improving mental status — titrated to 2–3 soft stools per day.
Adverse effects
Read the harms as too much effect (cramping, diarrhea, fluid/electrolyte loss) plus a few mechanism-specific dangers: magnesium in renal failure, fiber without water, mineral-oil aspiration, and stimulant dependence. Only certain agents carry boxed warnings.
Contraindications
The absolute bar is obstruction/acute abdomen; the rest are mechanism-specific cautions (magnesium and phosphate in renal disease, MiraLAX in kidney disease without a doctor’s supervision, mineral-oil aspiration, the pediatric age limits).
When to hold
Assess before giving — these findings mean hold the dose and act.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
Common questions
What are Laxatives used for?
How do Laxatives work?
What are the serious side effects of Laxatives?
When should a nurse hold Laxatives, and what safety checks apply?
Conditions treated
Lactulose here is not for constipation — it is an ammonia trap. Colonic bacteria turn it into acids; the acidic colon converts NH₃ to non-absorbable NH₄⁺ and expels it. Titrate to 2–3 soft stools/day: fewer means ammonia stays, more means dehydration — itself an encephalopathy precipitant. Rifaximin is added when lactulose alone is not enough.
Bulk-forming fibre supplements — NIDDK suggests "high-fiber foods or fiber supplements" for chronic symptoms, with fluid.
The teaching runs against the misuse. Laxatives "work in the gastrointestinal tract after the areas where caloric absorption has occurred primarily" — they do not prevent calories being absorbed. For constipation after stopping laxative misuse: "adequate hydration, exercise, and dietary fiber. If laxatives are still needed, low doses of polyethylene glycol powder or lactulose may be used." Stimulant-laxative abuse causes cathartic colon syndrome.
Lactulose — first-line. Label indication: "For the prevention and treatment of portal-systemic encephalopathy, including the stages of hepatic pre-coma and coma." The dose is adjusted "to produce 2 or 3 soft stools daily" (label); StatPearls: "About 70% to 80% of patients with hepatic encephalopathy show improvement with lactulose treatment." In acute overt HE it is repeated until the first bowel movement, then titrated. When the patient is in the coma stage "and the danger of aspiration exists," it is given as a retention enema, and "Cleansing enemas containing soap suds or other alkaline agents should not be used." It is also used for secondary prevention after an episode. Too much causes diarrhea, fluid loss, hypokalemia and hypernatremia. Contains galactose and lactose, so use "with caution in diabetes."
See also
Irreversibly shut off the stomach’s acid pump — the most powerful acid suppressors. Take before the first meal; think about long-term effects and the clopidogrel interaction.
Block the serotonin (5-HT3) trigger that drives vomiting from chemo, radiation, and surgery. A key risk is ondansetron’s dose-dependent QT prolongation.
Block the histamine (H2) arm of acid secretion — milder and faster than PPIs but shorter-acting and prone to tolerance. Famotidine is now one of the most commonly used agents; cimetidine has many interactions.
Neutralize stomach acid for fast, short heartburn relief. Separate from other drugs; mind the bowel effects.
Slow the gut to control diarrhea — but rule out infection first. High-dose loperamide is cardiotoxic.
Locally acting anti-inflammatories that induce and maintain remission in inflammatory bowel disease. Sulfasalazine’s sulfa half drives its side effects.
Sources
- Lactulose solution — hepatic-encephalopathy use, NH₃→NH₄⁺ trapping, titrate to 2–3 soft stools/day (FDA label) — FDA / DailyMed
- OsmoPrep (sodium phosphate) — acute phosphate nephropathy boxed warning (FDA label, 2010; product now discontinued) — FDA / DailyMed
- Laxatives — mechanisms, onset, adverse effects & obstruction caution — StatPearls (NCBI)
- FDA — Possible harm from exceeding recommended dose of OTC oral sodium phosphate (2014, via FDA web archive) — U.S. FDA
- Kristalose (lactulose) for oral solution — FDA label — DailyMed (NLM)
- Enulose (lactulose) solution — FDA label — DailyMed (NLM)
- LINZESS (linaclotide) — pediatric dehydration boxed warning, obstruction contraindication (FDA label) — DailyMed (NLM)
- TRULANCE (plecanatide) — pediatric dehydration boxed warning (FDA label) — DailyMed (NLM)
- MiraLAX (PEG 3350) — Drug Facts — DailyMed (NLM)
- Metamucil (psyllium) — Drug Facts: choking warning, full glass of fluid — DailyMed (NLM)
- Phillips’ Milk of Magnesia — Drug Facts: kidney disease, onset — DailyMed (NLM)
- Dulcolax (bisacodyl) tablets — Drug Facts — DailyMed (NLM)
- Dulcolax (bisacodyl) suppository — Drug Facts — DailyMed (NLM)
- Senokot (senna) — Drug Facts — DailyMed (NLM)
- Colace (docusate) — Drug Facts — DailyMed (NLM)
- Mineral oil (lubricant laxative) — Drug Facts — DailyMed (NLM)
- Drugs@FDA marketing status — MiraLAX, lactulose brands, OsmoPrep, Visicol, Linzess, Trulance — U.S. FDA (openFDA)
- Bisacodyl — contraindications (appendicitis, ileus, obstruction, perforation) — StatPearls (NCBI)
- Castor Oil — stimulant laxative contraindications — StatPearls (NCBI)
- Docusate — straining after MI/rectal surgery, mineral-oil interaction, dependence — StatPearls (NCBI)
- Abdominal Examination — bowel sounds — StatPearls (NCBI)
- Opioid-Induced Constipation — fiber, fluids, exercise — StatPearls (NCBI)
- Small Bowel Obstruction — signs, intraluminal pressure, perforation — StatPearls (NCBI)
- Large Bowel Obstruction — presentation — StatPearls (NCBI)
- Hypermagnesemia — clinical signs — StatPearls (NCBI)
- Cardiac Glycoside and Digoxin Toxicity — hypokalemia increases digoxin sensitivity — StatPearls (NCBI)
- Anal Fissures — stool softeners — StatPearls (NCBI)
- Anatomy, Abdomen and Pelvis: Anal Triangle — hemorrhoids and stool softeners — StatPearls (NCBI)
- Melanosis Coli — minimizing reliance on stimulant laxatives — StatPearls (NCBI)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.